Is immunotherapy an effective treatment for Alzheimer's disease?

PubWeight™: 0.77‹?›

🔗 View Article (PMID 15679924)

Published in Immun Ageing on November 12, 2004

Authors

Federico Licastro1, Calogero Caruso

Author Affiliations

1: Dipartimento di Patologia Sperimentale, Università di Bologna, Via S, Giacomo 14, 40126 Bologna, Italy. licastro@alma.unibo.it.

Articles citing this

Alzheimer's disease: new diagnostic and therapeutic tools. Immun Ageing (2008) 0.79

Articles by these authors

(truncated to the top 100)

Human immunosenescence: is it infectious? Immunol Rev (2005) 2.83

Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev (2006) 2.82

Is immunosenescence infectious? Trends Immunol (2004) 2.47

T cells and aging, January 2002 update. Front Biosci (2002) 2.14

Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing (2005) 1.99

The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators Inflamm (2010) 1.59

Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech Ageing Dev (2005) 1.49

Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmun Rev (2002) 1.48

Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol (2011) 1.37

Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes'. Trends Immunol (2002) 1.24

Immunosenescence and Cytomegalovirus: where do we stand after a decade? Immun Ageing (2010) 1.22

Role of persistent CMV infection in configuring T cell immunity in the elderly. Immun Ageing (2007) 1.21

A double-negative (IgD-CD27-) B cell population is increased in the peripheral blood of elderly people. Mech Ageing Dev (2009) 1.21

Report from the second cytomegalovirus and immunosenescence workshop. Immun Ageing (2011) 1.19

B cells in the aged: CD27, CD5, and CD40 expression. Mech Ageing Dev (2003) 1.17

Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation. Neurobiol Aging (2006) 1.17

Immunogenetics, gender, and longevity. Ann N Y Acad Sci (2006) 1.16

Role of Toll-like receptor 4 in acute myocardial infarction and longevity. JAMA (2004) 1.12

Inflammation, ageing and cancer. Mech Ageing Dev (2008) 1.12

TLR4 polymorphisms and ageing: implications for the pathophysiology of age-related diseases. J Clin Immunol (2009) 1.08

Inflammation and life-span. Science (2005) 1.07

Inflammation and prostate cancer. Future Oncol (2008) 1.04

Immunity & Ageing: a new journal looking at ageing from an immunological point of view. Immun Ageing (2004) 1.04

Biology of longevity: role of the innate immune system. Rejuvenation Res (2006) 1.03

Tumor necrosis factor-alpha -308A/G polymorphism is associated with age at onset of Alzheimer's disease. Mech Ageing Dev (2006) 1.03

IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection. Hum Immunol (2003) 1.01

A study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence. Ann N Y Acad Sci (2006) 1.01

Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res Rev (2008) 1.00

Alzheimer's disease and genetics of inflammation: a pharmacogenomic vision. Pharmacogenomics (2007) 1.00

Impact of CMV and EBV seropositivity on CD8 T lymphocytes in an old population from West-Sicily. Exp Gerontol (2007) 0.99

Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immunother (2005) 0.99

CCR5 receptor: biologic and genetic implications in age-related diseases. Ann N Y Acad Sci (2007) 0.98

B cells and immunosenescence: a focus on IgG+IgD-CD27- (DN) B cells in aged humans. Ageing Res Rev (2010) 0.98

Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production. J Alzheimers Dis (2010) 0.97

Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population. PLoS One (2010) 0.97

B cell immunosenescence: different features of naive and memory B cells in elderly. Biogerontology (2011) 0.97

IL-10 and TNF-alpha polymorphisms in a sample of Sicilian patients affected by tuberculosis: implication for ageing and life span expectancy. Mech Ageing Dev (2003) 0.97

Association between the interleukin-1beta polymorphisms and Alzheimer's disease: a systematic review and meta-analysis. Brain Res Rev (2008) 0.96

Pathophysiology of ageing, longevity and age related diseases. Immun Ageing (2007) 0.96

Memory B cell subpopulations in the aged. Rejuvenation Res (2006) 0.96

Role of cyclooxygenase-2 and 5-lipoxygenase polymorphisms in Alzheimer's disease in a population from northern Italy: implication for pharmacogenomics. J Alzheimers Dis (2010) 0.96

Biomarkes of aging. Front Biosci (Schol Ed) (2010) 0.95

Immunosenescence and anti-immunosenescence therapies: the case of probiotics. Rejuvenation Res (2008) 0.94

Immune profiling of Alzheimer patients. J Neuroimmunol (2011) 0.94

Zinc and inflammatory/immune response in aging. Ann N Y Acad Sci (2007) 0.94

Frequency of the HFE gene mutations in five Italian populations. Blood Cells Mol Dis (2003) 0.93

Mediterranean diet and healthy ageing: a Sicilian perspective. Gerontology (2014) 0.93

The extreme longevity: the state of the art in Italy. Exp Gerontol (2007) 0.93

Thrombotic thrombocytopenic purpura: a review of the literature in the light of our experience with plasma exchange. Blood Transfus (2012) 0.93

Can Alzheimer disease be a form of type 3 diabetes? Rejuvenation Res (2012) 0.92

The role of IL-1 gene cluster in longevity: a study in Italian population. Mech Ageing Dev (2003) 0.92

Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: a study in the Sicilian population. J Leukoc Biol (2005) 0.92

Allele frequencies of +874T-->A single nucleotide polymorphism at the first intron of interferon-gamma gene in a group of Italian centenarians. Exp Gerontol (2002) 0.92

Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications. Rejuvenation Res (2010) 0.92

Association between +1059G/C CRP polymorphism and acute myocardial infarction in a cohort of patients from Sicily: a pilot study. Ann N Y Acad Sci (2006) 0.91

B cell immunosenescence in the elderly and in centenarians. Rejuvenation Res (2008) 0.91

Inflammation, genetic background and longevity. Biogerontology (2010) 0.91

Association of Klotho polymorphisms with healthy aging: a systematic review and meta-analysis. Rejuvenation Res (2014) 0.91

Involvement of -308 TNF-alpha and 1267 Hsp70-2 polymorphisms and zinc status in the susceptibility of coronary artery disease (CAD) in old patients. Biogerontology (2006) 0.91

Human longevity within an evolutionary perspective: the peculiar paradigm of a post-reproductive genetics. Exp Gerontol (2007) 0.91

Pro-inflammatory genetic background and zinc status in old atherosclerotic subjects. Ageing Res Rev (2008) 0.90

1267 HSP70-2 polymorphism as a risk factor for carotid plaque rupture and cerebral ischaemia in old type 2 diabetes-atherosclerotic patients. Mech Ageing Dev (2005) 0.90

Systematic review by meta-analyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease. Brain Res Rev (2009) 0.89

LPS-mediated production of pro/anti-inflammatory cytokines and eicosanoids in whole blood samples: biological effects of +896A/G TLR4 polymorphism in a Sicilian population of healthy subjects. Mech Ageing Dev (2011) 0.89

Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease. Ann N Y Acad Sci (2006) 0.89

Pathophysiology of vascular dementia. Immun Ageing (2009) 0.88

Association between longevity and cytokine gene polymorphisms. A study in Sardinian centenarians. Aging Clin Exp Res (2004) 0.88

Inflammation, genes and zinc in Alzheimer's disease. Brain Res Rev (2007) 0.87

Association between C1019T polymorphism of connexin37 and acute myocardial infarction: a study in patients from Sicily. Int J Cardiol (2005) 0.87

Pharmacogenomics: a tool to prevent and cure coronary heart disease. Curr Pharm Des (2007) 0.87

Inflammatory mediators as biomarkers in brain disorders. Inflammation (2014) 0.86

Mediterranean diet and longevity: an example of nutraceuticals? Curr Vasc Pharmacol (2014) 0.86

Association between the HFE mutations and unsuccessful ageing: a study in Alzheimer's disease patients from Northern Italy. Mech Ageing Dev (2003) 0.86

Association between the HLA-DR alleles and longevity: a study in Sardinian population. Exp Gerontol (2003) 0.86

Gender-related immune-inflammatory factors, age-related diseases, and longevity. Rejuvenation Res (2010) 0.86

Inflammation, longevity, and cardiovascular diseases: role of polymorphisms of TLR4. Ann N Y Acad Sci (2006) 0.86

Association between the HFE mutations and longevity: a study in Sardinian population. Mech Ageing Dev (2003) 0.86

Weak D and partial D: our experience in daily activity. Blood Transfus (2012) 0.86

Pro-inflammatory genetic markers of atherosclerosis. Curr Atheroscler Rep (2013) 0.85

Gamma/delta T lymphocytes are affected in the elderly. Exp Gerontol (2002) 0.85

Association between platelet endothelial cellular adhesion molecule-1 polymorphisms and atherosclerosis: results of a study on patients from northern Italy. Rejuvenation Res (2010) 0.85

Remodelling of biological parameters during human ageing: evidence for complex regulation in longevity and in type 2 diabetes. Age (Dordr) (2011) 0.85

Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma. Ann N Y Acad Sci (2006) 0.85

PECAM-1/CD31 in infarction and longevity. Ann N Y Acad Sci (2007) 0.84

Role of environmental and genetic factor interaction in age-related disease development: the gastric cancer paradigm. Rejuvenation Res (2008) 0.84

Blood group does not appear to affect longevity a pilot study in centenarians from Western Sicily. Biogerontology (2011) 0.84

Inflammation, genes and zinc in ageing and age-related diseases. Biogerontology (2006) 0.83

Acute myocardial infarction and proinflammatory gene variants. Ann N Y Acad Sci (2007) 0.83

Immunological and immunogenetic markers in sporadic Alzheimer's disease. Aging Clin Exp Res (2006) 0.83

Changes of inflammatory mediators in obese patients after laparoscopic cholecystectomy. World J Surg (2010) 0.83

Association between the polymorphism of CCR5 and Alzheimer's disease: results of a study performed on male and female patients from Northern Italy. Ann N Y Acad Sci (2006) 0.83

Similarity and differences in elderly patients with fixed airflow obstruction by asthma and by chronic obstructive pulmonary disease. Respir Med (2007) 0.83

Allele frequencies of +874T --> A single nucleotide polymorphism at the first intron of IFN-gamma gene in Alzheimer's disease patients. Aging Clin Exp Res (2003) 0.83

A novel B cell population revealed by a CD38/CD24 gating strategy: CD38(-)CD24 (-) B cells in centenarian offspring and elderly people. Age (Dordr) (2012) 0.83

A study of age-related IgE pathophysiological changes. Mech Ageing Dev (2003) 0.83

Role of polymorphisms of CC-chemokine receptor-5 gene in acute myocardial infarction and biological implications for longevity. Haematologica (2008) 0.82

Mutations in the HFE gene and cardiovascular disease risk: an individual patient data meta-analysis of 53 880 subjects. Circ Cardiovasc Genet (2008) 0.82

Association between interleukin-10 polymorphisms and Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis (2012) 0.82

Mediterranean diet and longevity in Sicily: survey in a Sicani Mountains population. Rejuvenation Res (2012) 0.82

Ageing, longevity, exceptional longevity and related genetic and non genetics markers: panel statement. Curr Vasc Pharmacol (2014) 0.81